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Abstract 
 
In this work, we have prepared a new drug delivery system consisting of silica (SiO2) as 
the main carrier, while albumin acted as the co–carrier in order to control the release of 
drug. The system was prepared by simple wet chemical method. The efficiency of the 
designed system was tested in the delivery of a hydrophobic drug, curcumin through an 
in–vitro procedure. The results show that the release percentage of curcumin was 
increased with the presence of the co–carrier. The intermolecular interaction of 
curcumin with albumin and the competition between them to locate on the surface of 
silica affect the release system. Besides, the curcumin release amount was 
corresponded to the composition of the silica carrier in the systems. Consequently, the 
potential for silica/albumin use as a drug carrier was ascertained. 
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INTRODUCTION
 
 
Over the past six decades, drug release has been an important 
focus in the field of drug delivery. The evolvement in the drug–
delivery area led to the exploration of new dosing routes, for instance, 
transdermal, vaginal, pulmonary and sublingual (Wilson et al., 2011). 
New pharmaceutical compound or ‘drug’ with increasing complexity 
and more functions has been progressively formulated and designed 
by the experts (Barbe et al., 2004). The drug, either naturally derived 
or synthetically produced, are extensively used in controlled drug 
release in order to optimize bio–efficacy, treatment of particular 
illness and subsequently improving human life (Fu et al., 2010). Each 
drug has specific demands upon its administration in order to achieve 
an ideal therapeutic efficiency
 
Drug release refers to the process of transferring of drug solutes 
from the primary position in an incorporated matrix to the outer 
surface, and then to the release medium (Mhlanga et al., 2014).  The 
release process can be influenced by number of factors which are the 
interaction of the drug with the matrix, the properties of the solute and 
the release environment. In general, two important release 
mechanisms that associated in drug release are dissolution and 
diffusion. Dissolution is defined as a process of transferring a drug 
from its solid phase to the surrounding medium where it is influence 
by solubility and particle size (Siepmann et al., 2012). Diffusion of a 
substance occurs from regions that have the higher concentration to 
regions of lower concentration. The movement of the substance is the 
result of the gradient concentration and also associated with the 
Brownian motion of the molecules (Siepmann et al., 2012).
  
Silica particle has been used immensely used as drug carrier due 
to its favorable properties which are hydrophilic, non–toxic, excellent 
biocompatible and tunable porosity (Gangwar et al., 2013 and Barbe 
et al., 2004). Its hydrophilic character due to the presence of hydroxyl 
groups on its surface avoids its elimination by the reticuloendothelial 
system, where this would enhance circulation time of drug in blood 
stream (Horjacada et al., 2006). In addition, the use of SiO2 in 
cosmetic and foods additives have been approved by US Food and 
Drug Administration (FDA) as “Generally Recognized As Safe” 
(Steven et al., 2014). Most of the studies on drug delivery use 
amorphous xerogels (Quintanar–Guerrero et al., 2009), fumed silica 
nanoparticles or mesoporous SiO2
 
such as MCM–41 or SBA–15 
(Diab et al., 2017) 
 
In this work, we want to develop a new SiO2–based drug delivery 
system with the incorporation of protein as a co–carrier. It is 
suggested that the use of co–carrier could controlled the release 
amount of drug
 
since it can play a role in the intermolecular 
interaction within the system. Here, egg white protein or ovalbumin is 
used as the source of albumin. Ovalbumin consists of 385 amino acid 
residues with a molecular weight of 47 kDa. It has an internal 
disulfide bond and four free sulphydryl groups (Elzoghby et al., 
2012). Its tertiary structure was composed of nine α–helices and three 
β–sheets that folded into a compact globule supported mainly by the 
hydrogen bonds and disulfide bonds. Besides that, albumin can 
enhance the solubility of hydrophobic drug where it could bind to the 
hydrophobic pockets via albumin via hydrophobic or van der Waals 
interactions (Mohanta et al., 2013). The presence of numerous 
functional groups in protein residues allows the interaction of drug–
albumin and albumin–silica. Previously, albumin (human or bovine 
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serum) has been widely used as a drug carrier in the form of 
nanoparticles or microparticles (Elzoghby et al., 2012). The 
preparation techniques of albumin particles include desolvation 
(coacervation), emulsification and thermal gelation. Nevertheless, 
there were some issues that arise regarding on the techniques where; 
desolvation method require the use of crosslinking agent such as 
glutaraldehyde that could led to toxicity, oil residue and surfactant 
need to be remove in emulsification method and thermal stabilization 
method is selectively for heat–tolerate drug.  
Here, the incorporation of curcumin to the silica/albumin carrier 
will be carried out by using simple wet chemical method. The 
proposed method here promotes feasibility of the preparation step as 
well as ensuring the integrity of drug is not affected. There will be no 
employment of chemical modification to the carriers that would 
probably result in a covalent attachment between the drug and the 
carrier. This is merely important since the drug need to be certainly 
detached from the carrier matrix afterward. 
The ability of the silica/albumin act as a carrier was used in the 
in–vitro administration of hydrophobic drug, curcumin. Numerous 
studies on using curcumin as a therapeutic agent have been carried out 
due to its anti–oxidant, anti–inflammatory, anti–carcinogenic and 
anti–bacterial properties (Chereddy et al., 2013, Gangwar et al., 2013, 
Hatamie et al., 2012, Jithan et al., 2011 and Mathew et al., 2012). The 
anti–oxidant property of curcumin is contributed to the presence of 
phenolic –OH and β–diketone moiety that have the ability to scavenge 
the molecular species of active oxygen. However, its hydrophobic 
nature and poor bioavailability leads to low absorption, high rate of 
metabolism within the living system and rapid elimination from the 
body system. Curcumin undergoes rapid degradation in pH 7.4 buffer 
solution, where it is degraded more than 50% in 30 min release period 
(Leung et al., 2015). Gangwar et al., (2013) in his study has shown 
that silica:curcumin conjugates prepared by a modified Stöber 
method. By using this method, bioavailability character of curcumin 
was enhanced while its therapeutic activity remains intact. However, 
in the in–vitro study, 50% of curcumin has been already discovered in 
the dissolution medium within 7 h of release, where this result is quite 
discouraging for application that require a slow–release drug. 
Therefore, there is a need for extensive research on this matter, which 
do not only enhance the bioavailability of curcumin, but also to keep 
the multifunctional properties of the conjugated system. Fig. 1 shows 
the chemical structure of curcumin with the presence of phenolic –OH 
and β–diketone moiety.  
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Fig. 1
 
  Chemical structure of curcumin (Leung et al., 2015).
 
 
 
  
The resulting system was silica/albumin/curcumin 
(SiO2/Alb/Cur). The release of curcumin will be conducted through 
in–vitro procedure and the release medium used was phosphate buffer 
solution pH 7. The use of albumin as the co–carrier and its effect on 
release of curcumin from the system will be highlighted. In addition, 
we attempt to control the release of curcumin by varying the 
composition of SiO2
 
carrier. The rational reason for this attempt is to 
investigate the relationship of carrier towards the release of curcumin 
and its particular release mechanism. Consequently, the outcome of 
the release experiment will give insight of release mechanism of the 
systems. 
 
 
EXPERIMENTAL 
 
Materials 
Albumin/ovalbumin, from chicken egg white (crystallized and 
lyophilized, Sigma–Aldrich), tetraethoxysilane (TEOS, Acros), 
sodium borohydrate (NaBH4, QRec), curcumin (QRec), ammonia 
solution (NH3, 28%, QRec) and ethanol (Merck) were used without 
further purification. Buffer solution (potassium dihydrogen phosphate, 
pH 7.00, Merck) and deionized water (DI water) were used in the 
experiment.  
 
Instrumentations 
Synthesized silica–based drug delivery systems were 
characterized by diffuse reflectance UV–Visible spectroscopy (DR 
UV–Vis, Perkin Elmer Ultraviolet–visible Spectrometer Lambda 35), 
Fourier transform infrared–attenuated total reflectance spectroscopy 
(FTIR–ATR, Thermo Scientific Model Nicolet iS10), 
thermogravimetric analyzer (TGA, TGA/SDTG 851e METTLER 
TOLEDO), and scanning electron microscopy (SEM, JEOL JSM–
6390LV). UV–Visible spectrophotometer (Shimadzu 1800) was used 
to observe the amount of albumin and curcumin in the release 
medium.  
 
Preparation of SiO2–based system 
Four samples of SiO2–based drug delivery systems were prepared 
in this work and are summarized in Table 1. For comparison purpose, 
albumin/curcumin (Alb/Cur) sample with the weight ratio of 1.0/1.0 
(wt/wt) was prepared as a comparison purpose. Studies on the release 
mechanism of curcumin from the system were investigated by 
studying the effects of albumin as the co–carrier and the effect of the 
SiO2 compositions. Tetraethoxysilane (TEOS) has been used as the 
precursor for Stöber silica.  
 
Table 1  Experimental detail of SiO2–based drug delivery systems. 
 
SiO2–based system Weight ratio Abb. 
SiO2/Cur 10.0/1.0 S(10.0)C 
SiO2/Alb/Cur 10.0/1.0/1.0 S(10.0)AC 
 8.5/1.0/1.0 S(8.5)AC 
 6.0/1.0/1.0 S(6.0)AC 
 
Preparation of Silica/Curcumin (SiO2/Cur) 
SiO2 particles were prepared by hydrolysis and condensation of 
TEOS in ethanol, in the presence of ammonia as the catalyst following 
previous method (Ibrahim et al., 2011). Stöber silica was first 
prepared by ethanol (0.370 mL, 0.001664 mol), NH3 (0.042 mL, 
0.001664 mol), H2O (0.150 mL, 0.00832 mol) and the mixture 
solution was stirred for 5 minutes in a clean, empty glass vial (10.5 
mL). Under a gentle stirring condition, a mixture of TEOS (0.370 mL, 
0.001664 mol) in ethanol (0.370 mL, 0.001664 mol) was added 
dropwisely into the vial. Then, the solution containing silica in sol 
phase was stirred overnight to allow the completion of the hydrolysis 
process. Next, curcumin (0.01 g) was added directly into the pre–
synthesized silica sol under gentle stirring condition. The solution 
mixture was stirred at room temperature for 24 h. Then, the sample 
was dried at 40 °C in an oven overnight before being collected and 
kept in a desiccator.  
  
Preparation of Silica/Albumin/Curcumin (SiO2/Alb/Cur) 
SiO2/Alb/Cur systems (S(10.0)AC, S(8.5)AC and S(6.0)AC) were 
prepared according to below preparation procedure. For the 
preparation of S(10.0)AC, Stöber silica was first prepared by ethanol 
(0.370 mL, 0.001664 mol), NH3 (0.042 mL, 0.001664 mol), H2O 
(0.150 mL, 0.00832 mol) n and the mixture solution was stirred for 5 
minutes in a clean, empty glass vial (10.5 mL). Under a gentle stirring 
condition, a mixture of TEOS (0.370 mL, 0.001664 mol) in ethanol 
(0.370 mL, 0.001664 mol) was added dropwise into the vial. The 
solution was stirred overnight to allow the completion of the 
hydrolysis process.  Alb/Cur mixture was prepared with the weight 
ratio of 1.0/1.0 (wt/wt). For the preparation of Alb/Cur mixture, 
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albumin (0.01 g) was first weighed in a clean vial and dissolved in 
distilled water (3 mL). Under stirring condition, curcumin (0.01 g) 
was added into the solution. After 5 minutes of stirring, acetone (0.2 
mL) was added to fully homogenize the solution mixture. The mixture 
was then left under stirring for 3 h before being added to the pre–
synthesized silica in colloidal form. Afterwards, the mixture of 
Alb/Cur was placed into a clean beaker (25 mL). Under the gentle 
stirring condition, the pre–synthesized silica sol was added into the 
solution of Alb/Cur. The mixture was then left under stirring at room 
temperature for 24 h. Next, the mixture was transferred into a petri 
dish and covered with perforated aluminium foil. The sample was 
allowed to dry at room temperature for four days before being 
collected and kept in a desiccator. The similar steps were repeated for 
the preparation of S(8.5)AC and S(6.0)AC with the corresponding 
amount of silica 
 
Preparation of Albumin/Curcumin (Alb/Cur) 
Alb/Cur mixture was prepared with the weight ratio of 1.0/1.0 
(wt/wt). For the preparation of Alb/Cur mixture, albumin (0.01 g) was 
first weighed in a clean vial and dissolved in distilled water (3 mL). 
Under stirring condition, curcumin (0.01 g) was added into the 
solution. After 5 minutes of stirring, acetone (0.2 mL) was added to 
fully homogenize the solution mixture. The mixture was then left 
under stirring for 3 h before transferred into a petri dish and covered 
with perforated aluminium foil. The sample was allowed to dry at 
room temperature for four days before being collected and kept in a 
desiccator. 
 
Release Experiment  
An accurately weighed quantity of samples (50 mg) was added to 
30 mL of PBS pH 7 and stir gently at 37 °C. At a different time 
intervals, 3 mL of the buffer solution was removed, and replaced with 
3 mL of fresh medium. The sample was sonicated for 5 minutes and 
then centrifuged for 5 minutes at 4000 rpm to obtain a clear 
supernatant. The free albumin was detected at 280 nm and curcumin 
was identified at 427 nm by using a UV–Visible spectrophotometer. 
Albumin and curcumin content was detected by preparing a standard 
calibration curve of albumin and curcumin in the phosphate buffer 
solution prior to analysis.  
 
RESULTS AND DISCUSSION 
 
Fig. 2 shows the infrared spectra for (a) albumin, (b) curcumin, (c) 
Alb/Cur, (d) Stöber silica (e) S(10.0)C, (f) S(10.0)AC (g) S(8.5)AC 
and (h) S(6.0)AC. As seen in Fig. 2(a), albumin has a broad vibration 
peak at around 3293 cm–1. This vibration band was corresponding to 
the amide A band that consists of N–H stretching (Kong et al., 2007). 
Albumin also exhibits an intense amide I band at 1649 cm–1, 
corresponding to C=O stretching, while amide II band at 1541 cm–1 
corresponded to the out–of phase combination of in–plane C–N 
stretching and N–H bending of amide groups (Nafisi et al., 2011). The 
presence of amide I band (1600–1700 cm–1) is related to the protein 
backbone conformation and it is commonly used to study the 
conformational change of its secondary structure Significant peak at 
1396 cm–1 corresponding to the COO– of side chains in albumin can 
also be clearly seen. Notable peak at 3508 cm–1 in Fig.  2(b) of 
curcumin is due to the presence of free O–H in curcumin. Besides 
that, there is also a remarkable vibration peak at 1625 cm–1 that 
signifies C=O group, and more intense peak at 1507 cm–1 attributed to 
the C=C vibration band. The presence of aromatic C=C in curcumin 
were in the range of 1400–1520 cm–1. Vibration bands of the C–O–C 
group in the range of 1000–1200 cm−1 also are observed which were 
attributed to the symmetric and asymmetric configurations of the 
C−O−C chains (Hatamie et al., 2012 and Gangwar et al., 2013). The 
broad feature at around 3420 cm−1 on Fig.  2(d) was the characteristic 
vibration bands of the O–H stretching of surface silanols. The intense 
band appearing at 1104 cm−1 was assigned to –Si–O–Si– asymmetric 
stretching vibrations. The symmetric stretching vibration of –Si–O–
Si– was observed at 797 cm−1 and its bending mode appeared at 471 
cm−1. The vibrational peak at 952 cm−1 was attributable to the Si–O 
in–plane stretching vibrations of the silanol Si–OH groups. The low 
energy band at around 560 cm−1 was assigned to the defects in SiO2’s 
network (Gangwar et al., 2013 and Popat et al., 2012). 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 T
ra
ns
m
itt
an
ce
 (a
.u
.) 
300
0 
2000 1000 
Wavenumber (cm-1) 
 
1500 600 2500 3500 
3508 
 2962, 
2935 
 
 
 3074 
  1649  1541 
 
                                   
1104 
 952 
 
1093 
1094 
1098 
1098 
(c) 
(d) 
(b
) 
(a) 
(f) 
(e
) 
(g) 
(h) 
 797 
 
3293 
3290 
3508 
 
Fig. 2  FTIR spectra of samples (a) albumin, (b) curcumin, (c) Alb/Cur, 
(d) Stöber silica, (e) S(10.0)C, (f) S(10.0)AC, (g) S(8.5)AC and (h) 
S(6.0)AC. 
 
Referring to Fig. 2(c) of Alb/Cur, a minimal shift of amide A band 
of albumin (3293 to 3290 cm–1) can be observed. Then, there is no 
shifting shown by the vibration band of –OH group of curcumin at 
3508 cm–1. These results suggested that in the Alb/Cur system, 
albumin might not interact intermolecularly through the hydrogen 
bond between the N–H group of amide A of albumin (3293 cm–1) with 
the hydroxyl –OH of curcumin (3506 cm–1). However, we cannot 
further clarify that curcumin can be physically bonded through the 
enolic –OH group at 3375 cm–1 into the electronegative oxygen in the 
carbonyl backbone of albumin that stabilized protein secondary 
structure. This is due to the overlapping vibration peaks in the range 
of 1500–1700 cm–1. As shown in Fig. 2(e–h), the asymmetric 
stretching of –Si–O–Si– band in S(10.0)C, S(10.0)AC, S(8.5)AC and 
S(6.0)AC systems are shifted to the higher energy region. This reveals 
that albumin and curcumin might attach to the silanol surface of silica 
carrier. The vibration bands corresponded to the free –OH of 
curcumin was not present in all of the SiO2/Alb/Cur samples as being 
overlapped by the O–H stretching band of silanols of SiO2. Apart 
from that, there was overlapping of general vibration bands for 
albumin and curcumin in the range of 1640–1500 cm–1. These 
vibration bands include the stretching of C=O, N–H bend, and CN 
stretching of albumin, C=C, C=O and aromatic C=C of curcumin.  
Through FTIR spectra, it is impossible to identify the specific 
interaction of albumin (co–carrier) with curcumin, albumin with SiO2, 
and SiO2 with curcumin. However, it can be stipulated that albumin 
and curcumin were interacted with the SiO2 carrier through the silanol 
group of SiO2, as proved by the shifting of –Si–O–Si– asymmetric 
stretching band in Fig. 2(e–h). 
Fig. 3 shows DRUV spectra of samples (a) curcumin (b) Alb/Cur 
(c) S(10.0)C, (d) S(10.0)AC, (e) S(8.5)AC and (f) S(6.0)AC. 
Curcumin exhibits an absorbance peak at ~474 nm due to the π–π* 
transition of the conjugated diaryl heptanoid chromophore groups 
(Gangwar et al., 2013 and Hatamie et al., 2012). Fig. 3(b–f) shows 
that this characteristic peak is seen to be intact in Alb/Cur and 
SiO2/Alb/Cur systems. Broadening of signature absorbance peak with 
a bathochromic shift in Alb/Cur system might indicates the interaction 
of curcumin towards albumin. Then, the signature peak exhibited a 
hypsochromic shift as curcumin interacted with SiO2 carrier in the 
S(10.0)C, S(10.0)AC, S(8.5)AC and S(6.0)AC systems. Referring to 
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the Fig. 3(c–d), the signature peak was shifted to a different direction 
in S(10.0)C and  S(10.0)AC systems. The possible explanation that 
could justify this occurrence is due to the nature of interaction of 
curcumin with the albumin, and curcumin with the SiO2/albumin 
carrier in the S(10.0)C and  S(10.0)AC systems, respectively. Up to 
this stage, the effect of albumin as the co–carrier remain unclear  
(from the spectroscopic studies) as there is no difference shown by 
DRUV spectra of S(10.0)C and  S(10.0)AC systems. This matter will 
be discussed further in TGA analysis. 
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 Fig. 3  DRUV spectra of samples (a) curcumin, (b) Alb/Cur, (c) 
S(10.0)C, (d) S(10.0)AC, (e) S(8.5)AC and (f) S(6.0)AC. 
 
 
The morphology of Stöber SiO2 particles, SiO2/Alb/Cur systems 
and Alb/Cur are displayed in Fig. 4. As shown in Fig. 4(a), SiO2 
particles that were prepared following the Stöber method exhibits 
particle size of 100–300 nm. The sample of S(10.0)C in Fig. 4(b) 
revealed that the system has an irregular and heterogenous surface 
morphology. The surface shows random aggregates of SiO2 particles 
and an elongated–bar–like structures that can be attributed to the 
curcumin, similar to the morphology of untreated curcumin reported 
by Yadav et al., (2014). Incorporation of albumin as the co–carrier 
does bring forth change to the surface morphology of the synthesized 
SiO2–based system. It can be observed that S(10.0)AC, S(8.5)AC and 
S(6.0)AC systems in the Fig.  4(c–e) exhibited a homogenous surface 
morphology. The bar–like structure which was expected to be 
curcumin, was incorporated within the SiO2 particles together with the 
co–carrier. As shown in the Fig. 4(f), Alb/Cur sample demonstrate a 
heterogenous surface morphology where irregular block–like shape 
appeared.  
investigated using TG as shown in Fig. 5. Fig. 5(a) illustrated that 
Alb/Cur exhibits three stages of weight loss, where 3% of moisture 
was removed initially. The second stage of weight loss of the sample 
from 160–470 °C (45%) can be attributed to the collective degradation 
of albumin and curcumin that were loosely attached to one another or 
near to the sample surface. The degradation of curcumin has been 
reported to be in the range of 200–400 °C (Mathew et al., 2012). The 
weight loss of protein around 300 °C was caused by the breakdown of 
the amino acid residues, as well as the cleavage of the peptide bonds 
in the albumin (Aswathy et al., 2012). Albumin and curcumin that 
curcumin that interact strongly between them or located in the sample 
core was suggested to be degraded starting at 470–900 °C (46%).  
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4  SEM images of samples (a)
 
Stober SiO2, (b) S(10.0)C, (c) S(10.0)AC, (d) S(8.5)AC and (e)
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and
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Alb/Cur.
 
 
Thermal analysis of the SiO2–based drug delivery systems was 
(a)
S(10.0)AC, S(8.5)AC and   S(6.0)AC    system    was 6%, 3% and 4%, 
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Referring to Fig. 5(b), it can be observed that S(10.0)C exhibits 
three stages of weight loss. It is shown that 5% of water was removed 
initially. Then, the sample was further degraded from 200 °C to 500 
°C, with a mid–point at 300 °C. This 7% of weight loss can be 
attributed to the curcumin that was loosely incorporated between the 
SiO2 particles or curcumin that near to the surface of sample. The 
third weight loss of 6% in the range of 500 °C to 700 °C is might 
corresponded to degradation of curcumin that adsorbed strongly to the 
silanol’s surface of SiO2.  
TGA curve of S(10.0)AC, S(8.5)AC and S(6.0)AC in Fig. 5(c–e) 
demonstrates two weight losses. The moisture content of the 
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Alb/Cur, (b) S(10.0)C, (c) 
S(10.0)AC, (d) S(8.5)AC and (e)
 
S(6.0)AC.
 
 
respectively. The second weight loss of S(10.0)AC started at 150 °C, 
reaching mid–point at 310 °C and ended at 600 °C. The S(8.5)AC 
system then exhibited the second weight loss from 160 °C to 520 °C 
with a mid–point of 320 °C. As for the S(6.0)AC system, the second 
weight loss occurred in the range of 160 °C to 510 °C, reaching mid–
point of 320 °C. The second weight loss can be attributed to the 
gradual degradation of albumin and curcumin that was attached to the 
external surfaces of SiO2. Based on the results here, it can be seen that 
the degradation range of second weight loss of SiO2/Alb/Cur system 
was slightly delayed as the system has a higher composition of SiO2. 
It is suggested that a more stable system was attained when the 
amount of carrier was increased since higher –OH groups of SiO2 
were available for the attachment with albumin and curcumin. The 
difference of weight loss stage between S(10.0)C and S(10.0)AC 
proved that there was an effect of the co–carrier in the intermolecular 
interaction between curcumin and SiO2 carrier. 
The cumulative release percentage of the S(10.0)C, S(10.0)AC, 
S(8.5)AC and S(6.0)AC systems and its total release percentage are 
shown in Fig. 6 and 7. Referring to Fig. 6, it can be exclaimed that 
curcumin exhibit three stages of release. In the first stage of release, 
curcumin exhibited a quick or ‘burst’ release within 10 h release 
period. Curcumin that was located at or near to the surface of sample 
was released immediately into the buffer solution during the initial 
stage. Up to 20 h, a slow released of curcumin can be seen afterwards. 
In this stage, it is hypothesized that the concentration of curcumin 
between the system and the release medium has come near to the 
equilibrium state. Therefore, this resulting in a low release of 
curcumin in all of the systems. In the last stage, the release of 
curcumin was continued as a combined result of the disintegration of 
the silica carrier and the diffusion of curcumin along the diffusional 
medium. On the other hand, the highest release percentage of 
curcumin within 28 h was exhibited by the S(8.5)AC system (55%) as 
can be seen in Fig. 7. As for the S(6.0)AC, S(10.0)AC and S(10.0)C 
systems, the release percentage of curcumin founded was 44%, 39% 
and 31%, respectively. 
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Fig. 7  Total cumulative release of curcumin in 28 h. 
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Based on the observed experimental results, it can be justified that 
the use of albumin as the co–carrier and the composition variation of 
SiO2 in the system are interrelated to the cumulative release data of 
the systems. Firstly, it can be seen here that the use of albumin as the 
co–carrier here caused an increase of cumulative release percentage of 
curcumin. Referring to the Fig. 7, total release of curcumin from the 
S(10.0)C system is 31%. The presence of albumin as the co–carrier in 
the SiO2–based system caused an increase of curcumin amount up to 
39% (S(10.0)AC). The higher percentage of curcumin release of 
S(10.0)AC in contrast to the S(10.0)C system can be attributed to the 
intermolecular interaction of curcumin with the albumin network. In 
our case, albumin might undergo conformational change or structural 
rearrangement since protein is susceptible to the surrounding 
environment. During the preparation step, acetone has been used to 
increase the solubility of curcumin in water. The presence of 
electronegative oxygen atom in acetone can interrupted the intra–
molecular hydrogen bonds that stabilized the protein tertiary structure. 
As a result, the non–polar amino acid side chains that were located 
initially within the hydrophobic core are more flexible and hence 
available for interaction with curcumin. The interaction of albumin 
with curcumin also can increase the solubility of curcumin in the 
aqueous medium (Mohanta et al., 2013 and Thomas et al., 2014). The 
overall phenomenon discussed above explained the effect of albumin 
as the co–carrier that associated to the increase of cumulative release 
percentage of curcumin from S(10.0)AC as compared to the S(10.0)C 
system. Other factor that can contribute to the higher amount of 
curcumin release was albumin competed with curcumin in order to be 
adsorbed on the SiO2 surface. This indirectly decreases the availability 
of –OH group of SiO2 to be interacted with curcumin. The difference 
of the weight loss stages between the S(10.0)C and S(10.0)AC 
systems in the TG studies verify the effects of albumin as the co–
carrier in the SiO2–based systems. Schematic representation of the 
possible intermolecular interaction in the S(10.0)C and S(10.0)AC 
systems is given in Fig. 8. The figure demonstrated that curcumin 
interacted intermolecularly with albumin through hydrophobic 
interaction (aromatic side of curcumin with the aromatic and aliphatic 
side chains in albumin), and hydrogen bond (–OH enolic of curcumin 
with the C=O of albumin).  
Secondly, it can be pointed out that there is an effect of the 
composition of the SiO2 carrier towards the cumulative release 
percentage of curcumin. As can be seen in Fig. 6, release profile of the 
S(8.5)AC and S(6.0)AC systems show a different release pattern as 
compared to the S(10.0)AC systems. A higher burst release of 
curcumin up to 10 h was shown by S(8.5)AC (~40%) and S(6.0)AC 
systems (~35%) comparable to the S(10.0)AC systems (25%). Then, 
all of the systems continued to exhibit a slower release of curcumin 
from 10 h to 28 h. Referring to Fig. 7, the total cumulative release 
percentage of curcumin of the S(10.0)AC, S(8.5)AC and S(6.0)AC 
systems shown a different amount which was expected due to the 
SiO2 carrier composition. 
Based on these result, it can be realized that the release of 
curcumin are affected by the composition of SiO2 carrier. Curcumin 
was released in ‘burst’ from the S(8.5)AC and S(6.0)AC compared to 
the S(10.0)AC systems during the first stage. Due to the lower 
composition of the SiO2 carrier, the system provides lower capacity of 
primary interaction by the silanol groups. It was suggested that there 
are two affinity of interaction provided by SiO2 particle. The higher 
affinity of interaction between albumin and curcumin with SiO2 
particle was suggested to be developed through the silanol surface. 
Besides albumin and curcumin interacted to the surface of SiO2, they 
can also bind loosely in the secondary pore of SiO2. As the system 
have less amount of SiO2 carrier, more curcumin was attached loosely 
in between the SiO2 particles resulting in a quick release after the 
immersion of sample.  
 
 
 
  
              
          
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Fig. 8  Possible intermolecular interactions of SiO2, albumin and
 
curcumin
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In the case of the S(10.0)AC systems, less curcumin was founded 
in the buffer solution after 28 h release period (39%). Since the 
system have a higher amount of SiO2 carrier, more number of silanol 
groups were present for the attachment of curcumin. Besides that, the 
higher amount of silica carrier can decelerate the diffusion progress of 
curcumin during the release process.  Therefore, this factor explained 
the lower release amount of curcumin from S(10.0)AC in contrast to 
the S(8.5)AC and S(6.0)AC systems. S(10.0)AC systems is also a 
more stable system as proven by the delay of the degradation range of 
the second weight loss in TGA result. 
 Thirdly, it can be highlighted here that the total release 
percentage of curcumin from S(6.0)AC shows a decreasing trend as 
compared to the S(8.5)AC system (see Fig. 7). It is suggested that in 
this ratio, a good intermolecular interaction between albumin and 
curcumin has been formed, where this could decelerated the diffusion 
rate of curcumin in the diffusional medium. In other words, due to the 
decrease of SiO2 amount, higher number of interaction between 
 
 
CONCLUSION
 
 
In conclusion, we have successfully prepared new SiO2–based 
drug delivery system and studied the drug release mechanisms. The 
drug release mechanism is generally occurred through the 
disintegration of the carrier and the diffusion of the drug. The results 
show that the release of curcumin from the SiO2–based system can be 
controlled by the addition of albumin as the co–carrier and the 
composition of SiO2 carrier. The presence of albumin as the co–
carrier caused an increase of curcumin release due to the 
intermolecular interaction of albumin with the curcumin, and albumin 
competed with curcumin in order to be adsorbed on the silanol 
surfaces. The total release of curcumin from the SiO2/Alb/Cur systems 
and its release mechanism was strongly depended on the composition 
of silica carrier. The different strategies and intermolecular 
interactions described in this work may be useful in designing a 
sustainable and controlled drug release system, that can meet the 
medical demands of pharmaceutical applications. 
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albumin and curcumin were formed where this could led to the 
decreasing amount of curcumin. This deduction is in agreement to the 
TGA studies, where higher amount of organic content was degraded 
in the second weight loss stage of S(6.0)AC system. This result also 
might support the role of albumin as the co–carrier in the SiO2–based 
system.
